Patent delisted for Astellas drug LEXISCAN

Annual Drug Patent Expirations for LEXISCAN Lexiscan is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There are seventeen patents protecting…
The post Patent delisted for Astellas drug LEXISCAN appeared firs…


New patent for Astrazeneca drug CALQUENCE

Annual Drug Patent Expirations for CALQUENCE Calquence is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent for Astrazeneca drug CALQUENCE appeared first…


New patent for Pharmacyclics Inc drug IMBRUVICA

Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are twenty-nine patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appea…


New patent for Allergan Sales drug GELNIQUE

Annual Drug Patent Expirations for GELNIQUE Gelnique is a drug marketed by Allergan Sales Llc and is included in two NDAs. It is available from two suppliers. There are six…
The post New patent for Allergan Sales drug GELNIQUE appeared first on DrugPat…


Tablet dosed drug patent expirations by year

This chart shows the patent expirations for tablet dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Tablet dosed drug patent expirations by year appeared first on DrugPatentWatch …


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog